Tongri Liu
ALLIFE Medicine, Birmingham, UK
Biography
Tongri Liu (Tony) has completed his Ph.D. at the age of 27 years from University of Oxford, UK and Senior Research Scientist from ALLIFE Medicine Science and Technology Co. Ltd.. He is the director of ALLIFE Medicine UK Branch and Subsediary Companies and the representative of ALLIFE Medicine Science and Technology Co. Ltd., a Chinese Pharmaceutical Company specialised in iPSc derived cell and gene therapies. He has helped established the ALLIFE Medicine UK Branch and Subsediary Companies and is leading the clinical trial application with the MHRA in the UK for both iPSc-EPC and iPSc-Islet projects.